Compugen (CGEN) Current Leases (2019 - 2026)
Compugen's (CGEN) quarterly Current Leases came in at $559000.0 in Q1 2026, up 32.15% year-on-year from $423000.0 in Q1 2025, and up 7.29% quarter-over-quarter from $521000.0 in Q4 2025.
Compugen (CGEN) Current Leases (2019 - 2026) Analysis & Trends
Compugen has disclosed Current Leases across 8 years of filings, most recently posting $559000.0 for Q1 2026.
- Current Leases for Q1 2026 came in at $559000.0, up 32.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $559000.0 (up 32.15% YoY), and the FY2025 annual result was $521000.0, up 16.29% from the prior year.
- Current Leases came in at $559000.0 for Q1 2026 at Compugen, up from $521000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $764000.0 in Q1 2022 to a low of $423000.0 in Q1 2025.
- The 5-year median for Current Leases is $559000.0 (2026), against an average of $546058.8.
- Across the five-year window, Current Leases decreased 29.11% in 2024 and surged 32.15% in 2026, its largest moves.
- Compugen's Current Leases stood at $613000.0 in 2022, then advanced by 3.1% to $632000.0 in 2023, then fell by 29.11% to $448000.0 in 2024, then advanced by 16.29% to $521000.0 in 2025, then advanced by 7.29% to $559000.0 in 2026.
- The last three Current Leases figures came in at $559000.0 (Q1 2026), $521000.0 (Q4 2025), and $486000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | 559,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 559,000.00 |
| Dec 31, 2025 | 521,000.00 |
| Sep 30, 2025 | 486,000.00 |
| Jun 30, 2025 | 471,000.00 |
| Mar 31, 2025 | 423,000.00 |
| Dec 31, 2024 | 448,000.00 |
| Sep 30, 2024 | 447,000.00 |
| Jun 30, 2024 | 449,000.00 |
| Mar 31, 2024 | 441,000.00 |
| Dec 31, 2023 | 632,000.00 |
| Sep 30, 2023 | 592,000.00 |
| Jun 30, 2023 | 610,000.00 |
| Mar 31, 2023 | 617,000.00 |
| Dec 31, 2022 | 613,000.00 |
| Sep 30, 2022 | 595,000.00 |
| Jun 30, 2022 | 615,000.00 |
| Mar 31, 2022 | 764,000.00 |
| Dec 31, 2021 | 768,000.00 |
| Sep 30, 2021 | 760,000.00 |
| Jun 30, 2021 | 706,000.00 |